格隆汇2月26日｜Wind数据显示，周四（2月26日），共有2家公司限售股解禁，合计解禁量为3908.48万 股，按最新收盘价计算，合计解禁市值为11.84亿元。从解禁量来看，1家公司解禁股数超千万股。金禄 电子、中科美菱解禁量居前，解禁股数分别为3796.5万股、111.98万股。从解禁市值来看，1家公司解禁 市值超亿元。金禄电子、中科美菱解禁市值居前，解禁市值分别为11.66亿元、1873.44万元。从解禁股 数占总股本比例来看，1家公司解禁比例超10%。金禄电子、中科美菱解禁比例居前，解禁比例分别为 25.12%、1.16%。 ...

（文章来源：证券日报） 证券日报网讯 2月25日，中科美菱发布2025年年度业绩快报公告称，公司2025年实现营业收入 308544895.46元，同比增长4.32%；归属于上市公司股东的净利润19107093.28元，同比增长5.64%。 ...

Core Viewpoint - The company has undergone significant changes in leadership and governance, alongside plans to utilize idle funds for investment, while experiencing slight growth in revenue and net profit in the first three quarters of 2025 [1][5]. Group 1: Executive Changes - In January 2026, the company's chairman, Wu Dinggang, resigned, which may impact the company's governance structure [2]. Group 2: Company Structure and Governance - On December 24, 2025, the company held its third extraordinary shareholders' meeting of the year, where several resolutions were passed, including changes to the legal representative, nomination of candidates for the fourth board of directors, anticipated daily related transactions for 2026, provision of guarantees for wholly-owned subsidiaries, and the use of idle funds for cash management. Fang Xiujun was elected as the employee representative director, effective from December 24, 2025. These decisions may influence future operations [3]. Group 3: Fund Movements - On February 5, 2026, the company announced the use of 110 million yuan of its own funds to purchase financial products. The current balance of undated financial products is 230 million yuan, and the company plans to invest no more than 260 million yuan in bank financial products to enhance the efficiency of fund utilization [4]. Group 4: Performance and Operating Conditions - In the first three quarters of 2025, the company achieved operating revenue of 224 million yuan, representing a year-on-year increase of 4.75%. The net profit attributable to the parent company was 12.76 million yuan, reflecting a year-on-year growth of 8.19%. This historical data serves as a reference for the company's performance [5].

公司是高新技术企业、国家级专精特新"小巨人"企业。同时，公司先后荣获了国家技术发明奖二等奖、 中国国际工业博览会银奖、中国制冷学会科学技术进步一等奖、中国医疗器械行业十大科技创新品牌、 2020 中国设计红星原创奖、美国 UL 能效之星、安徽省科学技术奖二等奖、安徽省企业技 术中心、安 徽省工业设计中心、安徽省专利优秀奖、安徽省工业精品、合肥市科学技术奖、合肥市企业技术中心、 全国工人先锋号、合肥市工人先锋号和合肥十佳设计创新型企业、安徽省工人先锋号等国家、省、市级 别的各项荣誉称号。 2025年上半年，公司始终坚持"以技术为基础，以产品为载体，以市场为导向，以客户为中心"的经 营 理念，在生物医疗领域核心制冷技术上持续获得突破，助力生命科学仪器技术水平提升，加快国产替代 步伐。公司推行"聚焦样本生态，纵向深入样本库全链条；立足生命科学，横向拓展实验室通用设备领 域"产品协同策略，以"为用户创造价值"为导向，专注用户、成就客户，不断巩固市场竞争 地位，完善 国内外市场布局，向成为全球领先的生命科学领域定制化系统解决方案服务商的目标不断奋进。 业绩方面，2025年前三季度，公司实现营业收入2.24亿元，同比增长 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Views - The report highlights the competitive advantage of Qian Dama through its "community small store + daily clearance mechanism + warehouse and cold chain" model, which enhances supply stability and operational efficiency [3][24][35] - The report emphasizes the importance of emotional consumption themes and identifies high-quality companies in high-growth sectors, recommending specific companies across various segments [6][37] Summary by Sections Industry Overview - The retail and social service indices reported a decline of 1.47% and an increase of 1.53% respectively during the week of January 12-16, 2026 [5][13] - The internet e-commerce sector showed the highest growth, with a year-to-date increase of 11.18% [16][19] Company Highlights - Qian Dama has submitted its IPO application to the Hong Kong Stock Exchange, focusing on fresh food retail in the South China market, with a GMV of 9.8 billion yuan in 2024, significantly outperforming its competitors [24][25] - The company operates 2,983 stores, with 2,898 being franchise stores, contributing over 90% of its revenue [25][31] - The report recommends several companies based on their performance and market positioning, including: - Chaohongji, expected to achieve a net profit of 436-533 million yuan in 2025, driven by brand upgrades and channel expansion [39][43] - Meilitiantian Medical Health, projected to see a revenue increase of 28.2% in FY2025H1 [39] - Zhou Dafu, focusing on product structure optimization and store upgrades [39] Investment Themes - Investment Theme 1: Focus on high-end gold and fashion jewelry brands, recommending Chaohongji and Laopu Gold [6][37] - Investment Theme 2: Emphasize retail companies adapting to trends and AI-enabled cross-border e-commerce leaders, recommending Yonghui Supermarket and Aiyingshi [6][37] - Investment Theme 3: Highlight domestic beauty brands that meet emotional value and safety innovation, recommending Maogeping and Pola [6][37] - Investment Theme 4: Focus on differentiated medical beauty product manufacturers and leading medical beauty institutions, recommending Meilitiantian Medical Health and Aimeike [6][37]

Group 1 - The company Zhongke Meiling has completed the registration of industrial and commercial changes and the filing of its articles of association, obtaining a new business license [2] - The legal representative of the company has changed from "Wu Dinggang" to "Fang Rongxin" [2] - Other industrial and commercial registration items recorded in the business license have not changed [2]

Core Viewpoint - Zhongke Meiling announced a credit guarantee plan for its wholly-owned subsidiaries to address funding gaps and support their development [2] Group 1: Credit Guarantee Details - The company plans to provide a total credit guarantee of up to 30 million yuan for its subsidiaries Anhui Tuoxing Technology Co., Ltd. and Anhui Ling'an Medical Equipment Co., Ltd. [2] - The guarantee for Tuoxing Technology is capped at 10 million yuan, while the guarantee for Ling'an Medical is capped at 20 million yuan [2] - The guarantee period for both subsidiaries is set for one year, and they will provide full net asset collateral to Zhongke Meiling [2]

Core Viewpoint - Zhongke Meiling announced the approval of an investment plan using idle funds for financial management, with a maximum investment of 200 million RMB [2] Group 1: Investment Plan - The company and its subsidiaries plan to use up to 200 million RMB of idle funds for bank financial product investments [2] - The investment period is valid for one year from the date of approval at the second extraordinary general meeting of shareholders in 2024 [2] Group 2: Current Financial Status - As of now, the company has 150 million RMB in outstanding financial products, which includes the newly purchased products [2] - This amount represents 24.52% of the company's audited net assets for the year 2024 [2]

Core Viewpoint - Zhongke Meiling announced that its major shareholder, Zhongke Xianxing (Beijing) Asset Management Co., Ltd., plans to reduce its holdings by up to 1.93 million shares, not exceeding 2% of total shares, due to personal funding needs [1] Summary by Category - **Shareholder Actions** - The major shareholder intends to reduce its stake through centralized bidding or block trading within three months after the announcement [1] - The shares to be sold were acquired before the company went public [1] - **Financial Implications** - The reduction in shares is driven by the shareholder's personal funding requirements [1]

Group 1 - On November 6, a total of 8 companies had their restricted shares unlocked, with a total unlock volume of 69.52 million shares, equating to a market value of 1.892 billion yuan based on the latest closing price [1] - Nanjing Securities, Zhongke Meiling, and Transsion Holdings had the highest unlock volumes, with 26.57 million shares, 19.50 million shares, and 10.83 million shares respectively [1] - In terms of unlock market value, Transsion Holdings, Zhongke Meiling, and Nanjing Securities led with market values of 760 million yuan, 415 million yuan, and 226 million yuan respectively [1] Group 2 - Zhongke Meiling, Dike Co., and Transsion Holdings had the highest unlock ratios, with ratios of 20.16%, 2.42%, and 0.94% respectively [1]